We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
+31.58%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$250M
AUM Growth
+$80.2M
(+47%)
Cap. Flow
+$54.1M
Cap. Flow
% of AUM
21.67%
Top 10 Holdings %
Top 10 Hldgs %
36.89%
Holding
128
New
62
Increased
6
Reduced
21
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire Medical Systems
INSP
|
+$6.46M |
| 2 |
HOLX
Hologic
HOLX
|
+$3.37M |
| 3 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$2.9M |
| 4 |
STAAR Surgical
STAA
|
+$2.34M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$2.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$4.14M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$4.09M |
| 3 |
Abbott
ABT
|
+$3.63M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$3.54M |
| 5 |
Globus Medical
GMED
|
+$3.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.06% |
| 2 | Industrials | 1.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
LivaNova
LIVN
$4.4B
| $19.5M | 7.8% |
+195,000
| New | +$17.7M |
|
|
ATHN
2
CALL
DELISTED
Athenahealth, Inc.
ATHN
| $11.5M | 4.62% |
+72,500
| New | +$10.8M |
|
3
CALL
ICU Medical
ICUI
$4.21B
| $10.3M | 4.12% |
+35,000
| New | +$9.57M |
|
4
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $9.52M | 3.81% |
+100,000
| New | +$9.19M |
|
5
PUT
iShares Russell 2000 ETF
IWM
$79.8B
| $7.37M | 2.95% |
+45,000
| New | +$7.2M |
|
|
6
Inspire Medical Systems
INSP
$1.45B
| $7.14M | 2.86% |
+200,280
| New | +$6.46M |
|
|
7
ICU Medical
ICUI
$4.21B
| $7.05M | 2.82% |
24,000
-4,000
| -14% | -$1.09M |
|
|
8
LivaNova
LIVN
$4.4B
| $6.99M | 2.8% |
70,050
-2,050
| -3% | -$186K |
|
9
CALL
Boston Scientific
BSX
$69.5B
| $6.54M | 2.62% |
+200,000
| New | +$6.03M |
|
10
CALL
Centene
CNC
$30.7B
| $6.16M | 2.47% |
+100,000
| New | +$5.77M |
|
11
PUT
Mettler-Toledo International
MTD
$28.6B
| $5.79M | 2.32% |
+10,000
| New | +$5.7M |
|
12
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $5.01M | 2.01% |
60,000
-100,000
| -63% | -$8.29M |
|
|
NVRO
13
PUT
DELISTED
NEVRO CORP.
NVRO
| $4.79M | 1.92% |
+60,000
| New | +$4.98M |
|
14
Medtronic
MDT
$109B
| $4.28M | 1.72% |
50,000
+7,500
| +18% | +$626K |
|
|
GWPH
15
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.19M | 1.68% |
+30,000
| New | +$4.26M |
|
16
Madrigal Pharmaceuticals
MDGL
$10.8B
| $3.66M | 1.47% |
+13,100
| New | +$2.3M |
|
17
CALL
Qiagen
QGEN
$8.54B
| $3.62M | 1.45% |
+94,306
| New | +$3.47M |
|
|
SIEN
18
DELISTED
Sientra, Inc.
SIEN
| $3.59M | 1.44% |
18,390
-11,027
| -37% | -$1.75M |
|
|
HOLX
19
DELISTED
Hologic
HOLX
| $3.48M | 1.39% |
+87,500
| New | +$3.37M |
|
|
20
Globus Medical
GMED
$10.7B
| $3.41M | 1.37% |
67,500
-67,500
| -50% | -$3.52M |
|
21
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $3.39M | 1.36% |
+12,500
| New | +$3.38M |
|
|
ATHN
22
DELISTED
Athenahealth, Inc.
ATHN
| $3.34M | 1.34% |
21,000
-4,000
| -16% | -$593K |
|
|
AGN
23
DELISTED
Allergan plc
AGN
| $3.33M | 1.34% |
20,000
+10,000
| +100% | +$1.61M |
|
|
SYNH
24
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.28M | 1.32% |
+70,000
| New | +$2.9M |
|
|
25
STAAR Surgical
STAA
$1.21B
| $3.1M | 1.24% |
+100,000
| New | +$2.34M |
|
Similar funds
GMP
BCA
ONGA
RC
DOFI
SRA
SR
TC
Pura Vida Investments's Q2 2018 Portfolio in Review
As of Q2 2018, Pura Vida Investments held 128 positions worth $250M, up 47% from $169M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Pura Vida Investments deployed $54.1M of net new capital in Q2 2018, opening 62 new positions and adding to 6 existing holdings. Its largest new stake was Inspire Medical Systems: 200,280 shares worth $7.14M.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 52% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was Merck, an estimated $4.14M trimmed.
- Pura Vida Investments's largest Q2 2018 buy was Inspire Medical Systems: 200,280 shares worth $7.14M.
- Pura Vida Investments added most to Allergan plc in Q2 2018, an estimated $1.61M increase.
- Pura Vida Investments's biggest Q2 2018 reduction was Merck, cutting an estimated $4.14M.
- Pura Vida Investments fully exited Abbott in Q2 2018, selling an estimated $3.63M.
- Pura Vida Investments's ten largest holdings make up 37% of its $250M portfolio in Q2 2018.
- Pura Vida Investments opened 62 new positions and closed 36 in Q2 2018.
- Pura Vida Investments's portfolio value rose 47% quarter-over-quarter to $250M.
Based on Pura Vida Investments's 13F filing for Q2 2018, filed 14 Aug 2018.